2m 2m 2m 2m 2m 2m 2m
Incyte (INCY)
NASDAQ
$104.42+$0.76 (+0.73%)
Price as of Jun 23, 2026 5:44 PM EDT- $20.7BMarket Cap
- 54.12%1-Year Change
- BiotechnologyIndustry
Incyte (INCY)
$104.42+$0.76 (+0.73%)
INCY | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $103.66 | ||
Change | +$5.44 (+5.54%) | ||
Open | $99.79 | ||
High | $103.71 | ||
Low | $99.79 | ||
Previous Close | $98.22 | ||
Volume | 2,204,988 | ||
30-Day Average Volume | 2,143,996 | ||
1-Week Change | 1.65% | ||
1-Month Change | 6.69% | ||
1-Year Change | 54.12% | ||
3-Year Change | 67.44% | ||
5-Year Change | 21.82% | ||
Fundamentals | |||
Shares Outstanding | 199.8M | ||
Total Assets | $7.3B | ||
Market Cap | $20.7B | ||
Enterprise Value | $17.2B | ||
Period: QTR TTM FY | |||
Revenue | $1.1B | ||
Net Income | $303.3M | ||
Free Cash Flow | $320.7M | ||
EBIT | $343.6M | ||
EBITDA | $367.4M | ||
Net Working Capital | $4.0B | ||
EPS | $1.47 | ||
Enterprise Value/EBITDA | 47 | ||
Enterprise Value/Revenue | 16 | ||
P/B | 4 | ||
P/E | 71 | ||
PEG | 188 | ||
Price/Free Cash Flow | 65 | ||
Price/Operating Cash Flow | 56 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue